MedPath

Remifentanil use for sedation and pain managment during a painful treatment at the emergency department.

Recruiting
Conditions
remifentanil, target controlled infusion, procedural sedation, analgesia, recovery time, emergency department, propofol, fentanyl.procedurele sedatie, pijnstilling, hersteltijd, spoedeisende hulp.
Registration Number
NL-OMON28296
Lead Sponsor
Albert Schweitzer hospital, Dordrecht, The NetherlandsM.A.A. van Hooft
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

All the patients who need procedural sedation and analgesia at the emergency department or the observatorium of the Albert Schweitzer hospital location Dordwijk in Dordrecht, age 18 years and older, classified as ASA I en II.

Exclusion Criteria

Age under 18 years, hemodynamic and/or respiratory instable, classified as ASA III, IV and V, suspicion of elevated intra-cranial pressure, pregnancy, use of opiates at home, opiates administered before PSA procedure started (in the ambulance, on arrival at the emergency department), intoxication, known allergy for fentanyl propofol remifentanil soy or chicken proteins.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The recovery time ( time between last dose PSA medication and full recovery of the patient).
Secondary Outcome Measures
NameTimeMethod
- Adverse effects, complications.<br /><br>- Succesfull interventions.<br /><br>- Satisfaction of the specialist about performing the intervention. <br /><br>- Adequate analgesia during procedure. <br /><br>- Satisfaction patient.
© Copyright 2025. All Rights Reserved by MedPath